Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia
- PMID: 9400935
- PMCID: PMC2228179
- DOI: 10.1038/bjc.1997.571
Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia
Abstract
Squamous cell carcinoma of the cervix (SCC) is preceded by a premalignant condition known as cervical intraepithelial neoplasia (CIN). The majority of cases of CIN regress spontaneously; however, methods are needed to identify those lesions likely to progress. Increased blood vessel density, signifying angiogenesis, is an independent prognostic indicator in a number of cancers, although little is known about its significance in premalignant lesions. The aim of the present study was to determine the relationship between vessel density, expression of the potent angiogenic factor vascular endothelial growth factor (VEGF) and CIN grade. Using immunohistochemistry, mean vessel density (MVD) and VEGF expression were assessed in samples from 54 patients who had undergone cone biopsy for CIN or hysterectomy for SCC and from 16 patients with no cervical pathology. There were significant increases in MVD and VEGF expression from normal cervix through CIN I to CIN III to invasive SCC, but no difference in mean vessel diameter between groups. There was a strong correlation between mean vessel density and VEGF expression, and both were associated with histological grade of CIN. The original MVDs for a small group of patients later presenting with recurrent disease were found to be equal to or greater than the mean for their histological grade. We conclude that the onset of angiogenesis is an early event in premalignant changes of the cervix due, in part, to enhanced expression of VEGF by the abnormal epithelium.
Similar articles
-
Platelet-derived endothelial cell growth factor expression and angiogenesis in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix.Ann Diagn Pathol. 2000 Oct;4(5):286-92. doi: 10.1053/adpa.2000.17872. Ann Diagn Pathol. 2000. PMID: 11073333
-
Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.Gynecol Oncol. 2008 Sep;110(3):445-51. doi: 10.1016/j.ygyno.2008.04.038. Epub 2008 Jun 20. Gynecol Oncol. 2008. PMID: 18565574
-
Expression of vascular endothelial growth factor in the progression of cervical neoplasia and its relation to angiogenesis and p53 status.Anal Quant Cytol Histol. 2003 Dec;25(6):303-11. Anal Quant Cytol Histol. 2003. PMID: 14714296
-
Angiogenesis in benign, pre-malignant and malignant vulvar lesions.Anticancer Res. 2002 Nov-Dec;22(6C):3853-65. Anticancer Res. 2002. PMID: 12553005 Review.
-
[Remodeling of angiogenesis and lymphangiogenesis in cervical cancer development].Biomed Khim. 2015 Sep-Oct;61(5):579-97. doi: 10.18097/PBMC20156105579. Biomed Khim. 2015. PMID: 26539865 Review. Russian.
Cited by
-
Effects of Acanthus ebracteatus Vahl on tumor angiogenesis and on tumor growth in nude mice implanted with cervical cancer.Cancer Manag Res. 2012;4:269-79. doi: 10.2147/CMAR.S33596. Epub 2012 Aug 23. Cancer Manag Res. 2012. PMID: 22977311 Free PMC article.
-
Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer.Med Oncol. 2024 Jul 10;41(8):199. doi: 10.1007/s12032-024-02446-x. Med Oncol. 2024. PMID: 38985225 Review.
-
The Incorporation of Immunotherapy and Targeted Therapy Into Chemoradiation for Cervical Cancer: A Focused Review.Front Oncol. 2021 May 26;11:663749. doi: 10.3389/fonc.2021.663749. eCollection 2021. Front Oncol. 2021. PMID: 34123823 Free PMC article. Review.
-
Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior.Virology. 2007 Oct 10;367(1):168-74. doi: 10.1016/j.virol.2007.05.030. Epub 2007 Jun 28. Virology. 2007. PMID: 17602722 Free PMC article.
-
Efficacy and Safety of Apatinib for the Treatment of Advanced or Recurrent Cervical Cancer: A Single-Arm Meta-Analysis Among Chinese Patients.Front Pharmacol. 2022 Aug 11;13:843905. doi: 10.3389/fphar.2022.843905. eCollection 2022. Front Pharmacol. 2022. PMID: 36034824 Free PMC article.